CELZ — Creative Medical Technology Holdings Share News
0.000.00%
Last trade - 00:00- $4.88m
- -$3.81m
- $0.01m
Creative Medical rises on FDA's 'orphan drug' tag for transplantation therapy
Brief: Creative Medical Technology Holdings Receives FDA Orphan Drug Designation For CELZ-101
Creative Medical Technology Holdings Inc expected to post a loss of 86 cents a share - Earnings Preview
Brief: Creative Medical Technology Holdings Announces IRB Approval For FDA Cleared Phase 1/2 Clinical Trial Of Stemspine® Using Allostem™ Novel Cell Therapy To Treat Chronic Lower Back Pain
Creative Medical Technology Holdings Inc expected to post a loss of 83 cents a share - Earnings Preview
Creative Medical Technology Holdings Inc expected to post a loss of 83 cents a share - Earnings Preview
Brief: Creative Medical Technology Announces $2 Mln Share Repurchase Program
U.S. STOCKS ON THE MOVE-Gold miners, ImmunoGen, Oracle
Creative Medical falls on 1-for-10 reverse stock split
Brief: Creative Medical Technology Holdings Announces Reverse Stock Split
Brief: Creative Medical Technology - Got Confirmation Greenstone Biosciences Developed Human Induced Pluripotent Stem Cell Pipeline For Co's Immcelz Platform
Brief: Creative Medical Technology - Announces Next Milestone Achievements In Immcelz Platform Development
U.S. STOCKS ON THE MOVE-Brady, Madison Square Garden Entertainment, Bowlero
U.S. STOCKS ON THE MOVE-Hawkins, Netflix, Alibaba Group
U.S. STOCKS ON THE MOVE-Dole, Canada Goose, Regency Centers
Creative Medical up on positive data for pain treatment procedure
Brief: Creative Medical Announces Positive Top-Line Study Results For Chronic Lower Back Pain Utilizing Its Stemspine Procedure Using Allostem Allogenic Cell Line
U.S. STOCKS ON THE MOVE-SiriusPoint, Nutex Health, Barrick Gold
U.S. STOCKS ON THE MOVE-SiriusPoint, Shopify, Gold miners